ArticleOxidative medicine and cellular longevity2022

MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.

Yuxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.